German Mikheyev
Podiatrist · Altamonte Springs, FLNPI 1073993077
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Stryker at 33.8% of the total. Among podiatrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $130.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$9K
- Arthrex$8K
- Reel Surgical, Inc.$2K
- Treace Medical Concepts, Inc.$1K
- Smith+Nephew$881
- In2bones USA, LLC$811
- plus $4K from 29 others
What the payments were for
- Speaking & faculty fees$2,50010%
- Travel & lodging$7,24829%
- Food & beverage$10,40141%
- Education$5,15720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 58 | $8,542 |
| Arthrex | 38 | $8,025 |
| Reel Surgical, Inc. | 5 | $2,372 |
| Treace Medical Concepts, Inc. | 4 | $1,034 |
| Smith+Nephew | 24 | $881 |
| In2bones USA, LLC | 3 | $811 |
| DNE LLC | 1 | $437 |
| Paragon 28, Inc. | 4 | $397 |
| Sanara Medtech Inc. | 2 | $338 |
| Next Science LLC | 2 | $293 |
| Linvatec Corporation | 2 | $280 |
| Johnson & Johnson | 3 | $249 |
| Amgen(2 entities) | 8 | $226 |
| Trilliant Surgical LLC. | 1 | $207 |
| Integra Lifesciences Corporation | 7 | $170 |
| Paratek Pharmaceuticals, Inc. | 5 | $168 |
| Axogen | 2 | $137 |
| Anika Therapeutics, Inc. | 1 | $114 |
| Stability Biologics, LLC | 1 | $113 |
| Osiris Therapeutics Inc. | 1 | $110 |
| Kerecis Limited | 3 | $69 |
| Averitas Pharma Inc. | 2 | $49 |
| Lifenet Health | 1 | $35 |
| Globus Medical | 1 | $27 |
| Bioventus LLC | 2 | $26 |
| AbbVie | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Medtronic | 1 | $23 |
| Zyla Life Sciences, Inc. | 2 | $23 |
| Aroa Biosurgery Incorporated | 2 | $22 |
| Ascendis Pharma Endocrinology Inc | 1 | $20 |
| Abbott | 1 | $20 |
| Embody, Inc. | 2 | $17 |
| Organogenesis Inc. | 1 | $13 |
| Nalu Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HOFFMANN$1,577
- VARIAX$1,518
- ALLOWRAP$1,148
- COBRA$777
- PROstep$707
- CoLink$691
- ASNIS$608
- Actishield$500
- FIXOS$490
- BIO4$477
- PROPHECY$466
- ALLOGRAFT$430
- CITREFIX$428
- SONICANCHOR$423
- ORTHOLOC 3DI$412
- Lapiplasty$398
- T2$391
- INFINITY$384
- Stravix$368
- CellerateRx$338
How this compares
$25,307 in reported general payments places this provider in the 95th percentile of 588 podiatrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 13 | $5,265 |
| Ciclopirox | 18 | $579 |
| Doxycycline Hyclate | 46 | $336 |
| Ketoconazole | 12 | $290 |
| Gabapentin | 24 | $256 |
| Celecoxib | 11 | $155 |
| Cephalexin | 21 | $126 |
| Methylprednisolone | 12 | $105 |
| Meloxicam | 24 | $88 |
| Mupirocin | 14 | $78 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $881 | $5,26513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 588 podiatrist providers in Florida.
Other podiatrist in Altamonte Springs
- James CottomSarasota$1.8M
- Caroline KiserFleming Island$206K
- Adam PerlerLargo$160K
- Desmond BellJacksonville$125K
- Jeffrey KarrLakeland$101K
- Marie WilliamsAventura$96K
- Todd BrennanTampa$88K
- Robert HooverLake Mary$71K
- Daniel BrandweinPompano Beach$70K
- John TorregrosaMiami$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.